Athanassios Tsakris Ekaterini Papadimitriou John Douboyas Fotini Stylianopoulou Evangelos Manolis
10.3201/eid0805.010387
Emerg Infect Dis
2002 May;8(5):536-7.
CC BY
https://pubmed.ncbi.nlm.nih.gov/11996696/
Anti-Bacterial Agents / pharmacology Drug Resistance, Multiple, Bacterial Staphylococcal Infections / microbiology Staphylococcus / drug effects Staphylococcus / isolation & purification Teicoplanin / pharmacology Vancomycin / pharmacology
Anti-Bacterial Agents / pharmacology Drug Resistance, Multiple, Bacterial Staphylococcal Infections / microbiology Staphylococcus / drug effects Staphylococcus / isolation & purification Teicoplanin / pharmacology Vancomycin / pharmacology Case Reports Letter Adult Anti-Bacterial Agents / therapeutic use Gentamicins / pharmacology Gentamicins / therapeutic use Greece Humans Male Microbial Sensitivity Tests Middle Aged Staphylococcal Infections / drug therapy Staphylococcus / genetics Staphylococcus / physiology Teicoplanin / therapeutic use Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use Vancomycin / therapeutic use Anti-Bacterial Agents Gentamicins Teicoplanin Vancomycin Trimethoprim, Sulfamethoxazole Drug Combination
PMC2732498
11996696
Emergence of vancomycin-intermediate Staphylococcus aureus and S. sciuri, Greece
2002